Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Aug 13 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding the closure of a USFDA inspection at its formulation manufacturing plant in Ahmedabad. The inspection was a Pre-Approval Inspection for three products and concluded with no observations. This announcement serves as a disclosure in accordance with regulatory requirements.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 13, 2025, titled "Closure of USFDA inspection at Zydus formulation manufacturing plant at SEZ II, Ahmedabad".

Zydus Lifesciences Limited on 6ix

In the deck

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases